Bagci S - Search Results

1

C reactive protein levels in non-alcoholic fatty liver disease.

Dogru T, Genc H, Bagci S. Dogru T, et al. Among authors: bagci s. J Hepatol. 2012 Feb;56(2):507-8; author reply 508-10. doi: 10.1016/j.jhep.2011.06.030. Epub 2011 Aug 31. J Hepatol. 2012. PMID: 21888877 Free article. No abstract available.

2

Hyperuricemia in non-alcoholic fatty liver disease.

Dogru T, Genc H, Tapan S, Bagci S. Dogru T, et al. Among authors: bagci s. Aliment Pharmacol Ther. 2011 Oct;34(8):1042-3; author reply 1043-4. doi: 10.1111/j.1365-2036.2011.04828.x. Aliment Pharmacol Ther. 2011. PMID: 21933215 Free article. No abstract available.

3

Adipocytokine levels in nonalcoholic fatty liver disease.

Dogru T, Ercin CN, Tapan S, Kantarcioglu M, Kara M, Bagci S. Dogru T, et al. Among authors: bagci s. Hepatology. 2009 Jul;50(1):326-7; author reply 327-8. doi: 10.1002/hep.23029. Hepatology. 2009. PMID: 19489074 No abstract available.

4

Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.

Kilciler G, Genc H, Tapan S, Ors F, Kara M, Karadurmus N, Ercin CN, Karslioglu Y, Kilic S, Bagci S, Erbil MK, Dogru T. Kilciler G, et al. Among authors: bagci s. Ups J Med Sci. 2010 Nov;115(4):253-9. doi: 10.3109/03009734.2010.500062. Epub 2010 Aug 23. Ups J Med Sci. 2010. PMID: 20731535 Free PMC article.

5

Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis.

Genc H, Dogru T, Tapan S, Kara M, Ercin CN, Aslan F, Kantarcioglu M, Karslioglu Y, Sertoglu E, Erbil MK, Bagci S. Genc H, et al. Among authors: bagci s. Scand J Gastroenterol. 2011 Nov;46(11):1355-61. doi: 10.3109/00365521.2011.603163. Epub 2011 Jul 19. Scand J Gastroenterol. 2011. PMID: 21770819

6

Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.

Genc H, Dogru T, Kara M, Tapan S, Ercin CN, Acikel C, Karslioglu Y, Bagci S. Genc H, et al. Among authors: bagci s. Ann Hepatol. 2013 Jul-Aug;12(4):548-55. Ann Hepatol. 2013. PMID: 23813132 Free article.

7

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.

Sonmez A, Nikolic D, Dogru T, Ercin CN, Genc H, Cesur M, Tapan S, Karslioğlu Y, Montalto G, Banach M, Toth PP, Bagci S, Rizzo M. Sonmez A, et al. Among authors: bagci s. J Clin Lipidol. 2015 Jul-Aug;9(4):576-82. doi: 10.1016/j.jacl.2015.03.010. Epub 2015 Apr 4. J Clin Lipidol. 2015. PMID: 26228676

8

Insulin resistance in prediction of esophageal varices.

Dogru T, Ercin CN, Tapan S, Polat Z, Gulsen M, Bagci S. Dogru T, et al. Among authors: bagci s. Hepatology. 2009 May;49(5):1775-6; author reply 1776. doi: 10.1002/hep.22875. Hepatology. 2009. PMID: 19333912 No abstract available.

9

Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease.

Ercin CN, Dogru T, Tapan S, Karslioglu Y, Haymana C, Kilic S, Sonmez A, Yesilova Z, Uygun A, Gulsen M, Bagci S, Kemal Erbil M. Ercin CN, et al. Among authors: bagci s. Dig Dis Sci. 2010 Apr;55(4):1128-34. doi: 10.1007/s10620-009-0817-1. Epub 2009 May 14. Dig Dis Sci. 2010. PMID: 19440836

10

Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

Dogru T, Genc H, Tapan S, Ercin CN, Ors F, Aslan F, Kara M, Sertoglu E, Bagci S, Kurt I, Sonmez A. Dogru T, et al. Among authors: bagci s. Diabetes Res Clin Pract. 2012 Apr;96(1):47-52. doi: 10.1016/j.diabres.2011.11.022. Epub 2011 Dec 19. Diabetes Res Clin Pract. 2012. PMID: 22189171

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page